glp 1 and vertigo GLP-1 meds like semaglutide (Ozempic/Wegovy) tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk What is the appropriate workup

Report any new or persistent symptoms to your healthcare provider during treatment

Its a more direct approach that targets the root cause of pigmentation from within

Consistent with other GLP-1 agonists, orforglipron labeling is expected to include the standard boxed warning about thyroid C-cell tumors and a contraindication in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

doi: 10.1186/s13643-023-02307-0 84

As per CNBC , list prices for Zepbound and Lillys diabetes treatment Mounjaro are both above US$1,000 a month, and uneven employer coverage has left roughly half of people with commercial insurance unable to start or stay on obesity treatment